MOUNTAIN VIEW, Calif., July 24, 2018 /PRNewswire/ -- With $5.6 million in Series A funding
Now available for pre-order, the Beddr SleepTuner is the initial step in the company's plan to deliver the industry's first integrated, digital approach to understanding and improving sleep. The SleepTuner's innovations are based on validated sleep science, providing users with insights into how breathing and sleep position impact health.
As many as 54 million adults struggle with their breathing while they sleep, and these problems significantly impact their physical and emotional well-being. In fact, poor sleep quality comes at a high cost. Frost & Sullivan estimates that undiagnosed breathing issues cost the U.S. more than $149 billion annually and increase the risk for chronic conditions, such as high blood pressure, type 2 diabetes and depression.
"Working with leading sleep medicine experts, we're bringing science into consumers' homes with the first comprehensive solution that helps individuals understand factors impacting their sleep," said Mike Kisch, co-founder and CEO of Beddr. "The Beddr SleepTuner helps people objectively understand the impact of sleep position, weight loss, alcohol consumption, as well as current treatments on overall sleep quality. Every morning, an individual will be presented with clinical grade insights and actions that may improve breathing, increase sleep duration, reduce snoring and improve recuperation."
Integrated Approach Guides Users to Better Sleep
The Beddr approach integrates a clinical-grade sleep sensor, mobile app and predictive analytics to provide personalized insights and actions. The SleepTuner's compact sensor is designed for comfort and ease of use when worn while sleeping over the course of multiple nights. It captures and correlates many key data points that provide deeper insights into the causes of sleep issues, including blood oxygen saturation, stopped breathing events, heart rate, heart rate spikes and sleep position. The SleepTuner connects wirelessly with the Beddr mobile app, guiding users through the sleep tuning process. The app compares each sleep assessment result to the prior one so users can see the impact of sleep tuning over time.
Unlike consumer sleep trackers that provide few insights and may have questionable accuracy, Beddr will ship an FDA-listed solution that leverages the science used in sleep labs. Now these clinical-grade insights are available directly to consumers at an affordable price.
"The Beddr SleepTuner is based on the best practices we use in a sleep clinic," said Brandon R. Peters, M.D., a practicing neurologist and board-certified sleep physician at Virginia Mason Medical Center in Seattle, who also sits on Beddr's clinical advisory board. "As more and more people come to understand the importance of high-quality sleep, the demand for sleep expertise is exploding, and yet the supply of board-certified sleep physicians cannot keep up with demand. Existing solutions on the market have limitations; they're either inaccessible to most people due to high cost and complexity, or they are not accurately gathering the right information to deliver clinically valid insights. We need to manage this gap and find new approaches to solve our nation's sleep problems. Beddr is doing just that."
New research from Parks Associates' study of U.S. broadband households, "Sleep and IoT: Behaviors, Awareness, and Opportunities," reports that 57 percent of consumers suffer with at least one sleep problem and 42 percent are concerned their health will worsen due to poor sleep quality.
"There is a clear opportunity for tech players to create products that not only track sleep, but also address sleep issues, and consumers show a willingness to pay for these kinds of products," said Jennifer Kent, research director and project manager of the Parks Associates' study. "Consumers report a high interest in devices that provide personalized insights and recommend actionable steps to improve their sleep; 61 percent of consumers are very interested in sleep tech features that can clinically improve the quality of sleep."
Series A Supports Commercial Launch
The Series A funding will support the commercial launch of the Beddr SleepTuner, as well as further development of the company's integrated sleep approach. In the future, Beddr expects to offer seamless access to board-certified sleep physicians, personalized treatment options, and ongoing coaching and support to drive improved outcomes at lower costs.
"I've experienced the sleep medicine system first hand. Ultimately, it helped me, but it took a long time for me to find the best solution to my chronic sleep problems. We invested in Beddr because we believe sleep disorders are vastly under-diagnosed and under-treated, and that the Beddr system can make a real difference," said Kiki Broe, partner at Three Leaf Ventures. "Beddr's team is the perfect combination of seasoned leadership and repeat entrepreneurs from medical device companies like Shockwave Medical; consumer marketing expertise at Johnson and Johnson; and technology innovators from companies like Amazon and Mint."
The Beddr SleepTuner can be preordered now from beddrsleep.com for early fall delivery. The suggested retail price is $149, but the SleepTuner is being offered at an introductory price of $99 while supplies last.
Beddr is a health technology company with a mission to improve the quality of life for millions of individuals through the first integrated, digital approach to understanding and improving sleep. Founded by a team of successful digital health entrepreneurs with proven track records of creating new markets and rapidly scaling successful companies, Beddr is backed by Three Leaf Ventures, the Stanford-StartX Fund, and top experts in sleep medicine. Based in Mountain View, Calif., with offices in Seattle, Beddr was founded in 2016. For more information, visit www.beddrsleep.com/.
View original content:http://www.prnewswire.com/news-releases/beddr-to-launch-new-solution-for-improving-sleep-with-5-6-million-in-series-a-funding-300685346.html
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All